SE9303612D0 - New use - Google Patents
New useInfo
- Publication number
- SE9303612D0 SE9303612D0 SE9303612A SE9303612A SE9303612D0 SE 9303612 D0 SE9303612 D0 SE 9303612D0 SE 9303612 A SE9303612 A SE 9303612A SE 9303612 A SE9303612 A SE 9303612A SE 9303612 D0 SE9303612 D0 SE 9303612D0
- Authority
- SE
- Sweden
- Prior art keywords
- medicament
- pla2
- heparin
- phospholipases
- low
- Prior art date
Links
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9303612A SE9303612D0 (sv) | 1993-11-02 | 1993-11-02 | New use |
AU81195/94A AU8119594A (en) | 1993-11-02 | 1994-11-02 | Use of low anticoagulant heparinderivatives |
PCT/SE1994/001030 WO1995012403A1 (en) | 1993-11-02 | 1994-11-02 | Use of low anticoagulant heparinderivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9303612A SE9303612D0 (sv) | 1993-11-02 | 1993-11-02 | New use |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9303612D0 true SE9303612D0 (sv) | 1993-11-02 |
Family
ID=20391615
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9303612A SE9303612D0 (sv) | 1993-11-02 | 1993-11-02 | New use |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU8119594A (sv) |
SE (1) | SE9303612D0 (sv) |
WO (1) | WO1995012403A1 (sv) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6001820A (en) * | 1995-03-31 | 1999-12-14 | Hamilton Civic Hospitals Research Development Inc. | Compositions and methods for inhibiting thrombogenesis |
US5763427A (en) * | 1995-03-31 | 1998-06-09 | Hamilton Civic Hospitals Research Development Inc. | Compositions and methods for inhibiting thrombogenesis |
US5744457A (en) * | 1995-03-31 | 1998-04-28 | Hamilton Civic Hospitals Research Development Inc. | Compositions and methods for inhibiting thrombogenesis |
US5980865A (en) * | 1995-08-18 | 1999-11-09 | Baker Norton Pharmaceuticals, Inc. | Method for treating late phase allergic reactions and inflammatory diseases |
US5767269A (en) * | 1996-10-01 | 1998-06-16 | Hamilton Civic Hospitals Research Development Inc. | Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics |
MX2020009877A (es) * | 2018-03-27 | 2021-01-08 | Brian Lohse | Péptidos neutralizantes de miotoxina. |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4879282A (en) * | 1987-03-17 | 1989-11-07 | Saliba Jr Michael J | Medical application for heparin and related molecules |
AU6204594A (en) * | 1993-02-22 | 1994-09-14 | Ulrich-Christoph Von Arnim | Use of heparins for the treatment of inflammatory or immunological diseases |
-
1993
- 1993-11-02 SE SE9303612A patent/SE9303612D0/sv unknown
-
1994
- 1994-11-02 WO PCT/SE1994/001030 patent/WO1995012403A1/en active Application Filing
- 1994-11-02 AU AU81195/94A patent/AU8119594A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU8119594A (en) | 1995-05-23 |
WO1995012403A1 (en) | 1995-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69920757D1 (de) | Immunsuppressive wirkungen von pteridinderivaten | |
DE69108048T2 (de) | Derivate von hydroxaminsäure und von n-hydroxyharnstoff sowie ihre verwendung. | |
BRPI9908182B8 (pt) | composições de proteína de matriz para cura de feridas | |
DE69526120T2 (de) | Verwendung von nebivolol als anti-atherogenisches mittel | |
UA49869C2 (uk) | Нафтил-заміщені похідні бензимідазолу, фармацевтична композиція, спосіб лікування (варіанти) та спосіб інгібування людського фактора | |
DE69710065D1 (de) | Androsten-derivate | |
DE69731610D1 (de) | Orale verabreichung wirksamer mengen von hyaluronsäure | |
EA200500804A1 (ru) | Топические противоинфекционные композиции | |
SE9602931L (sv) | Ny medicinsk användning | |
ATE336997T1 (de) | Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen | |
EA199900542A1 (ru) | Соединения сульфоновой кислоты или сульфониламино-n-(гетероаралкил)-азагетероциклиламида | |
DK1167354T3 (da) | Racemisk huperzin A | |
PT888327E (pt) | Derivados de benzopirano que possuem uma accao antagonistica dos leucotrienos | |
BR9809678A (pt) | Derivados de triptolìdeo úteis no tratamento de doenças autoimunes | |
BRPI0414887A (pt) | métodos de tratamento, prevenção, retardo do inìcio ou redução dos efeitos de citocinas pró-inflamatórias em um mamìfero e de tratamento, prevenção, retardo do inìcio de uma condição associada com um efeito de citocinas pró-inflamatórias em um mamìfero, e, composição farmacêutica | |
SE9303612D0 (sv) | New use | |
DE69705110T2 (de) | Topische pharmazeutische zusammensetzungen, welche heparin enthalten | |
DE69111974D1 (de) | Verwendung von Lithium zur Behandlung oder Prophylaxe von Molluscum contagiusum. | |
YU39598A (sh) | Upotreba duloksetina i njegova farmaceutska smeša | |
NO20003510D0 (no) | Fett-bindende polymerer | |
NO990450L (no) | Behandling av sinnslidelser | |
DE69103773T2 (de) | Derivate von hydroxaminsäure die lipoxygenase hemmen. | |
ATE222768T1 (de) | Ctla-8 in kombination mit g-csf oder mit g-csf und il-6, und verwendung vom ctla-8 zur behandlung von infektionen | |
PT1058544E (pt) | Inibicao da actividade do tnf | |
HUP9903679A2 (hu) | Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására |